CD8A and neoplasm: CD9−CD81+ pDCs induce regulatory T cells and are immunosuppressive, whereas CD9+CD81− pDCs secrete type I interferon (IFNα) and drive anti-tumour immunity via activation of cytotoxic CD8+ T cells [89, 90].